SEC Comment Letter for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Aug 3, 2010

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: Aug. 3, 2010 · CIK: 0000818686 · Accession: 0000000000-10-043961

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-16174

Date

July 8, 2010

Author

Not clearly detected

Form

UPLOAD

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)

Letter

July 8, 2010 Mr. Eyal Desheh Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street P.O. Box 3190 Petach, Tikva 49131, Israel Re: Teva Pharmaceutical Industries Limited Form 20-F for the Fiscal Year Ended December 31, 2009 File No. 000-16174

Dear Mr. Desheh:

We have completed our review of your Form 20-F and do not have any further comments at this time. Sincerely,

Gus Rodriguez Accounting Branch Chief

Show Raw Text

July 8, 2010

Mr. Eyal Desheh Chief Financial Officer  Teva Pharmaceutical Industries Limited     5 Basel Street P.O. Box 3190 Petach, Tikva 49131, Israel
Re: Teva Pharmaceutical Industries Limited
  Form 20-F for the Fiscal Year Ended December 31, 2009
File No. 000-16174

Dear Mr. Desheh:

We have completed our review of your Form  20-F and do not have any further comments
at this time.
Sincerely,

Gus Rodriguez Accounting Branch Chief

SecProbe.io